{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif

Survey Questionnaire

(To be filled only by physician)

  1. As per your clinical practice, what is the approximate number of patients diagnosed with Dry eye disease (DED) every month? *

  2. As per your clinical practice, which is the most common age group in patients diagnosed with Dry eye disease (DED)? *

  3. As per your clinical practice, which is the most common causes in patients diagnosed with Dry eye disease (DED), as observed in your practice? (Tick all applicable)*
  4. What percentage of your dry eye patients have coexisting autoimmune conditions contributing to their symptoms? *

  5. What is your primary method of diagnosing dry eye disease? *

  6. Which additional diagnostic tests do you use to assess dry eye severity? *

  7. How often do you reassess patients' progress during their treatment for dry eye disease? *

  8. Which lifestyle modifications do you recommend to patients for managing dry eye symptoms? *

  9. Which environmental factors do you emphasize to patients to manage dry eye symptoms? *

  10. In your experience, what role does diet play in managing dry eye disease? *

  11. When should meibomian gland dysfunction (MGD) be assessed for patients with moderate grade dry eye? *

  12. In cases of meibomian gland dysfunction, what treatment do you usually recommend? *

  13. Which type of artificial tears do you recommend most often? *

  14. Which of the following artificial tears do you recommend most often? *

  15. How do you approach treatment in patients with both dry eye disease and glaucoma? *

  16. What is the primary goal when managing mild grade dry eye? *

  17. Which of the following artificial tears do you recommend most often in mild grade dry eye? *

  18. When should punctal occlusion be considered for patients with mild grade dry eye? *

  19. How often do you use tear stimulants like cyclosporine in your treatment approach for mild grade dry eye? *

  20. What percentage of your dry eye patients require long-term maintenance therapy with cyclosporine? *

  21. When managing moderate grade dry eye, at what point should patients be referred to a specialist? *

  22. What do you recommend as the first line approach to managing moderate grade dry eye? *

  23. Do you perform in-office treatments for moderate dry eye disease, such as intense pulsed light therapy or lipiflow? *

  24. Which intervention is typically reserved for severe cases of dry eye that are refractory to other treatments? *

  25. Which therapy is recommended for patients with severe grade dry eye who are intolerant to or fail topical treatments? *

  26. What is the primary objective when managing severe grade dry eye? *

  27. Which therapy is recommended as a long-term management strategy for patients with chronic dry eye? *

  28. When do you refer patients to a specialist in oculoplastic surgery? *

  29. How do you assess patients' response to treatment over time? *

  30. Which dry eye treatment options do you find most cost-effective for patients? *